DiviDrip · IMDX

IMDX — Insight Molecular Diagnostics Inc.

IMDX is Insight Molecular Diagnostics Inc. (Healthcare) — a non-dividend-paying stock. Trading at $4.09. Market cap: $131M. Capital Quality Rank: 7/100 — Systemic risk.

Stock snapshot

Price$4.09
Market cap$131M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)7 / 100 · Systemic risk
Altman Z-score zoneDistress

About IMDX

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Listed2015Employees58HQNashville, TNSectorHealthcareWebsiteimdxinc.com

Related non-dividend companies

Other non-dividend stocks investors research alongside IMDX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is IMDX's current stock price?

IMDX (Insight Molecular Diagnostics Inc.) is currently trading at $4.09.

Does IMDX pay a dividend?

IMDX (Insight Molecular Diagnostics Inc.) does not currently pay a regular dividend.

What is IMDX's Capital Quality Rank?

IMDX has a Capital Quality Rank of 7/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track IMDX in DiviDrip

Add IMDX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow